Skip to main content
. 2015 Mar 14;6(12):10366–10373. doi: 10.18632/oncotarget.3590

Figure 1. Sox2 expression is low or undetectable in triple negative breast cancer cell lines.

Figure 1

Western blot depicting Sox2, and Oct4A/B protein expression across ER− and ER+ breast cancer cell lines. Ntera2, a malignant human pluripotent embryonic carcinoma cell line, acts as a positive control for Sox2 and Oct4A/B.